Abstract
<div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://bioinsights.blob.core.windows.net/uploads/Z Forbes copy.jpeg" data-image="1"></div><div class="author-det"> <b>Alexandria Forbes</b> has served as MeiraGTx’s President, Chief Executive Officer and a member of the board of directors since March 2015. Prior to joining MeiraGTx, Dr Forbes served as Senior Vice President of Commercial Operations at Kadmon Holdings, Inc., a biopharmaceutical company, from September 2013 to April 2015. Prior to Kadmon Holdings, Inc., Dr Forbes spent 11 years as a healthcare investor at Sivik Global Healthcare, a healthcare hedge fund, from September 2000 to November 2008, and at Meadowvale Asset Management, a healthcare hedge fund, from January 2010 to June 2012. Before entering the hedge fund industry, Dr Forbes was a Human Frontiers/Howard Hughes postdoctoral fellow at the Skirball Institute of Biomolecular Medicine at NYU Langone Medical Center from March 1997 to September 2000. Prior to this, Dr Forbes was a research fellow at Duke University, and also at the Carnegie Institute at Johns Hopkins University. Dr Forbes received an MA in Natural Sciences from Cambridge University and a PhD in Molecular Genetics from Oxford University. </div></div></div>
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call